Open AccessP596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE
Author(s) -
Bomben R.,
Rossi F. M.,
Vit F.,
Bittolo T.,
Zucchetto A.,
Papotti R.,
Tissino E.,
Pozzo F.,
Degan M.,
Zaina E.,
Cattarossi I.,
Nanni P.,
Marasca R.,
Reda G.,
Laurenti L.,
Olivieri J.,
Chiarenza A.,
Ballotta L.,
Cuneo A.,
Gentile M.,
Morabito F.,
Tafuri A.,
Zaja F.,
Foà R.,
Di Raimondo F.,
Del Poeta G.,
Gattei V.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845272.72415.cb
Subject(s) - ibrutinib , medicine , concomitant , chronic lymphocytic leukemia , oncology , context (archaeology) , cohort , leukemia , biology , paleontology